Leap Therapeutics Inc LPTX

NAS: LPTX | ISIN: US52187K1016 14/11/2024

2,890 USD (-3,67%)

(-3,67%) 14/11/2024

Grafiek Leap Therapeutics Inc

Grafiek Leap Therapeutics Inc

1 dag1d -3,67%
1 week1w -10,80%
1 maand1m 26,20%
3 maanden3m 17,48%
6 maanden6m 3,21%
1 jaar1j 80,62%
5 jaar5j 348,55%

Leap Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

12 augustus 2024 · Leap Therapeutics Reports Second Quarter 2024 Financial Results · Persbericht

13 mei 2024 · Leap Therapeutics Reports First Quarter 2024 Financial Results · Persbericht

11 april 2024 · Leap Therapeutics Announces $40 Million Private Placement · Persbericht

18 maart 2024 · Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results · Persbericht

16 januari 2024 · Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium · Persbericht

3 januari 2024 · Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference · Persbericht

2 januari 2024 · Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients · Persbericht

11 december 2023 · Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium · Persbericht

13 november 2023 · Leap Therapeutics Reports Third Quarter 2023 Financial Results · Persbericht

5 september 2023 · Leap Therapeutics to Participate at Upcoming Investor Conferences · Persbericht

Profiel Leap Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.leaptx.com

Hoofdzetel: Cambridge, Massachusetts Verenigde Staten

Werknemers: 34

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe